c

Ophthalmology Therapeutics: Does current pipeline innovation hold the potential to affect the future ophthalmology market?

This Frontier Pharma: Ophthalmology Therapeutics assesses first-in-class innovation in the ophthalmology pipeline, highlighting key trends in the distribution of these products.

Pune, India - March 14, 2018 /MarketersMedia/ —

The pipeline is varied in terms of molecular targets and molecule types. Products acting on the immune system and neurotransmitter signaling are the most prevalent, but no single target dominates by any clear margin. There are a total of 194 first-in class pipeline products in development for ophthalmologic indications 38% of the 512 pipeline products for which there is a disclosed molecular target. Encompassing gene therapies, slowing of the visual cycle and antisense therapies, the pipeline appears robust and has huge potential to strengthen treatment options for ophthalmological disorders.

Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-ophthalmology-therapeutics-gene-therapies-and-first-in-class-targets-offer-novel-treatments-for-substantial-unmet-needs-in-a-pipeline-dominated-by-angiogenic-and-immune-signaling-drugs

Reasons To Buy
• Understand the current clinical and commercial landscape. This includes a comprehensive study of disease pathogenesis, diagnosis and prognosis, and the treatment options available.
• Visualize the composition of the ophthalmological disorders market in terms of dominant molecule types and targets, and understand the current unmet needs and how they can be addressed. This knowledge allows a competitive understanding of gaps in the market.
• Analyze the ophthalmological disorders pipeline and stratify by stage of development, molecule type and molecular target. There are strong signs in the pipeline that the industry is seeking novel approaches to treating ophthalmological disorders to overcome the overwhelming level of unmet need.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising early-stage targets have been reviewed in greater detail.
• Identify commercial opportunities in the ophthalmological disorders deals landscape by analyzing trends in licensing and co-development deals, and a curated list of ophthalmological disorder therapies that have not yet been involved in deals, and may offer potential investment opportunities.

Get this report at: https://www.themarketreports.com/report/buy-now/935550

In the past the ophthalmological disorders therapy area has suffered from a lack of full understanding of the pathophysiology and underlying mechanisms of the diseases. However, as this knowledge has improved vastly in recent years, potential targets have been identified for treatment. As well as the main disorders previously mentioned, there is also interest in developing treatments for indications such as allergic conjunctivitis and retinitis pigmentosa. The approval of a gene therapy for retinitis pigmentosa is indicative of this progress, and represents the first gene therapy approved for an inherited condition by the FDA.

Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935550

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/ophthalmology-therapeutics-does-current-pipeline-innovation-hold-the-potential-to-affect-the-future-ophthalmology-market/314326

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-ophthalmology-therapeutics-gene-therapies-and-first-in-class-targets-offer-novel-treatments-for-substantial-unmet-needs-in-a-pipeline-dominated-by-angiogenic-and-immune-signaling-drugs%20%20

Source: MarketersMedia

Release ID: 314326

Latest News

Weather suspends fourth round of Barbasol Championship

Jul 23, 2018

NICHOLASVILLE, Ky. — A thunderstorm suspended the fourth round of the PGA Tour's Barbasol Championship until Monday morning. Sunday's third stoppage of play at Champions Trace at Keene Trace Golf Club came with the four leaders — Hunter Mahan, Robert Streb, Tom Lovelady and Troy Merritt at 18-under par — and four other contenders waiting to begin the round. The tournament will resume at 7:30 a.m. on Monday. Lightning caused one delay, and play was stopped earlier in the afternoon to clear water that accumulated on the course following a morning of steady and sometimes-heavy rain. Inclement weather has plagued...

Spieth's title defense at British Open ends without a bang

Jul 23, 2018

CARNOUSTIE, Scotland — Defending champion Jordan Spieth wasn't the only one struggling to gain traction on the wind-swept final day at Carnoustie. But he was one of just two in the 79-player field who failed to make birdie, shooting 76 and sliding from a three-way tie atop the leaderboard at 9 under at the start into a tie for ninth by the end. A bogey, double-bogey run at Nos. 5 and 6 let a handful of contenders squeeze past Spieth, who owns three major championships, and bogeys at two of the last four holes killed his chance of catching up....

Molinari survives wild day to win British Open

Jul 23, 2018

CARNOUSTIE, Scotland — Francesco Molinari didn't get the loudest cheers for the best golf at British Open. He was overlooked for so much of Sunday playing alongside Tiger Woods, who caused pure pandemonium at Carnoustie by taking the lead in the final round of a major for the first time in nine years. Molinari settled for the best cheer of them all. The last one. Amid so much chaos — seven players atop the leaderboard, six of them still tied on the back nine — Molinari played a steady hand by going the entire weekend without a bogey and finishing...

Ice-cold Molinari repels a slew of challengers at Carnoustie

Jul 23, 2018

CARNOUSTIE, Scotland — Rory McIlory spun around and let out a roar after making a 35-foot eagle putt. Justin Rose clenched his fist after taming the 18th hole for a fourth straight day. Xander Schauffele kept his composure amid the chaos of an ever-changing leaderboard. Kevin Kisner? He stuck around like he has done all week. In a wild finish to the British Open, what all four ended up needing was a mistake or two from Francesco Molinari down one of the toughest closing stretches in golf. It didn't happen. McIlroy, Rose, Schauffele and Kisner finished in a tie for...

Column: This version of Woods seems like a nostalgia act

Jul 23, 2018

CARNOUSTIE, Scotland — All around him on a windy summer day on the links of Carnoustie, the leaders were imploding as Tiger Woods moved into the lead at the turn. It felt like old times at the British Open, as familiar as his Sunday red shirt and the swarm of fans that cheered his every shot. Then Woods imploded, too, and there's something that's become increasingly familiar about that. If this was the Woods of 15 years ago, he likely would be "the champion golfer of the year," as they say over here, and have his name on the claret...

Search
Broaden News

5 Stars Discovery brings you to the stories from people around the world sharing on the finest luxury resorts, high-end city hotels, and exclusive hideaway to make sure you’ll get the premium experience.

Contact us: sales@starsdiscovery.com